KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 112 filers reported holding KYMERA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,094 | -39.5% | 1,805,346 | 0.0% | 1.08% | -16.3% |
| Q2 2023 | $41,505 | -22.4% | 1,805,346 | 0.0% | 1.29% | -59.5% |
| Q1 2023 | $53,492 | +7.2% | 1,805,346 | -9.7% | 3.18% | +14.1% |
| Q4 2022 | $49,920 | -99.8% | 2,000,000 | +33.3% | 2.79% | +99.9% |
| Q3 2022 | $32,655,000 | +65.8% | 1,500,000 | +50.0% | 1.39% | +32.5% |
| Q2 2022 | $19,690,000 | -53.5% | 1,000,000 | 0.0% | 1.05% | -40.6% |
| Q1 2022 | $42,320,000 | -33.3% | 1,000,000 | 0.0% | 1.77% | +2.8% |
| Q4 2021 | $63,490,000 | +170.2% | 1,000,000 | +150.0% | 1.72% | +227.6% |
| Q3 2021 | $23,496,000 | +93.8% | 400,000 | +60.0% | 0.53% | +113.8% |
| Q2 2021 | $12,125,000 | +24.8% | 250,000 | 0.0% | 0.25% | +43.0% |
| Q1 2021 | $9,715,000 | -37.3% | 250,000 | 0.0% | 0.17% | -48.3% |
| Q4 2020 | $15,500,000 | +91.9% | 250,000 | 0.0% | 0.33% | +69.9% |
| Q3 2020 | $8,078,000 | – | 250,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 639,059 | $37,538,000 | 24.22% |
| BVF INC/IL | 3,180,658 | $186,832,000 | 7.29% |
| Deer IX & Co. Ltd. | 615,895 | $36,178,000 | 3.72% |
| Asymmetry Capital Management, L.P. | 89,071 | $5,232,000 | 3.14% |
| Redmile Group, LLC | 2,793,708 | $164,102,000 | 2.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,260 | $21,103,000 | 1.77% |
| CLOUGH CAPITAL PARTNERS L P | 271,000 | $15,919,000 | 0.96% |
| Rock Springs Capital Management LP | 732,927 | $43,052,000 | 0.90% |
| Eagle Health Investments LP | 37,000 | $2,173,000 | 0.69% |
| Avidity Partners Management LP | 514,500 | $30,222,000 | 0.67% |